Luisa Carbognin

2.6k citations
67 papers · 1.3k indexed · 1 hit paper · h-index 20
Topics
Breast Cancer Treatment Studies (19 papers)Lung Cancer Treatments and Mutations (16 papers)Cancer Genomics and Diagnostics (13 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
Partner nations
ItalyMalaysiaSpain

In The Last Decade

Luisa Carbognin

64 papers receiving 1.3k citations

Hit Papers

Differential Activity of Nivolumab, Pembrolizumab and MPD...20152026201820222015100200300

Peers

Luisa Carbognin
Comparison fields: 5 of 76
  • Oncology 928
  • Pulmonary and Respiratory Medicine 402
  • Molecular Biology 337
  • Cancer Research 320
  • Immunology 259
Replace Alexandros Xyrafas with:
Alexandros Xyrafas Switzerland
Lorena Incorvaia Italy
Serafín Morales Spain
Véronique D’Hondt France
Giulia Pasello Italy
Nicola Battelli Italy
Shuqiang Yuan China
Tamami Morisaki Japan
Sebastiano Buti Italy
Alexios Matikas Sweden
Luisa Carbognin relative to Alexandros Xyrafas Switzerland Alexandros Xyrafas's profile →
Citations per field
00.5×1.5×2.2×
Alexandros Xyrafas · 1×
Citations per year

Countries citing papers authored by Luisa Carbognin

Since Specialization
Citations

This map shows the geographic impact of Luisa Carbognin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luisa Carbognin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luisa Carbognin more than expected).

Fields of papers citing papers by Luisa Carbognin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luisa Carbognin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luisa Carbognin. The network helps show where Luisa Carbognin may publish in the future.

Co-authorship network of co-authors of Luisa Carbognin

This figure shows the co-authorship network connecting the top 25 collaborators of Luisa Carbognin. A scholar is included among the top collaborators of Luisa Carbognin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luisa Carbognin. Luisa Carbognin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 1
3 0
4 4
5 1
6 2
7 4
8 27
9 10
10 2
11 22
12 20
13 1
14 30
15 14
16 38
17 49
18 9
19
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancersbreakdown →
375
20 6

About Luisa Carbognin

Luisa Carbognin is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 67 papers that have together received 1.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (19 papers), Lung Cancer Treatments and Mutations (16 papers) and Cancer Genomics and Diagnostics (13 papers). The work is most often cited by research in Oncology (928 citations), Cancer Research (320 citations) and Pulmonary and Respiratory Medicine (402 citations). Luisa Carbognin has collaborated with scholars based in Italy, Malaysia and Spain. Frequent co-authors include Emilio Bria, Giampaolo Tortora, Sara Pilotto, Isabella Sperduti, Matteo Brunelli, Aldo Scarpa, Michèle Milella, Diana Giannarelli, Ida Paris and Anna Caliò. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026